Disphanurat, W. . and Srisantithum, B. . (2022) “Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined with Hyaluronic Acid versus 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: A randomized Evaluator-blind Trial”, Asian Medical Journal and Alternative Medicine, 22(-), p. S117. Available at: https://asianmedjam.com/index.php/amjam/article/view/1287 (Accessed: 14 December 2025).